Cell Source, Inc. (CLCS): Shareholders' Equity

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$18.54M
As of 2024-12-31
-$20.14M
As of 2025-03-31
$17.0K2012-12-31: $17.0K2013-12-31: -$697.3K2014-12-31: -$3.78M2015-12-31: -$5.76M2016-12-31: -$6.24M2017-12-31: -$4.56M2018-12-31: -$4.92M2019-12-31: -$5.74M2020-12-31: -$7.95M2021-12-31: -$9.83M2022-12-31: -$12.63M2023-12-31: -$15.61M2024-12-31: -$18.54M-$18.54M
2012-12-31 Shareholders' Equity (USD) 2024-12-31
Period endedShareholders' EquityChange YoYSource filing
2024-12-31-$18.54Mn/m2026-04-07, Balance as of period end
2023-12-31-$15.61Mn/m2026-04-07, Balance as of period end
2022-12-31-$12.63Mn/m2024-06-24, Balance as of period end
2021-12-31-$9.83Mn/m2023-08-08, Balance as of period end
2020-12-31-$7.95Mn/m2022-04-15, Balance as of period end
2019-12-31-$5.74Mn/m2021-04-15, Balance as of period end
2018-12-31-$4.92Mn/m2020-03-30, Balance as of period end
2017-12-31-$4.56Mn/m2019-04-01, Balance as of period end
2016-12-31-$6.24Mn/m2018-07-25, Balance as of period end
2015-12-31-$5.76Mn/m2018-07-25, Balance as of period end
2014-12-31-$3.78Mn/m2016-04-14, Balance as of period end
2013-12-31-$697.3Kn/m2015-03-13, Balance as of period end
2012-12-31$17.0Kn/a2014-03-25, Balance as of period end